VEGF production in COPD represents a mechanism to compensate for impaired lung function and hypoxia, but it has a role in attenuating the immunity vigilance when COPD coexists with advanced NSCLC [90]. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.